Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Equity Ratio: 2020-2025

Historic Equity Ratio for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to 0.51.

  • Maravai Lifesciences Holdings' Equity Ratio rose 6.10% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 6.10%. This contributed to the annual value of 0.57 for FY2024, which is 7.81% up from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Equity Ratio stood at 0.51, which was down 2.53% from 0.52 recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Equity Ratio peaked at 0.57 during Q4 2024, and registered a low of 0.16 during Q1 2021.
  • Its 3-year average for Equity Ratio is 0.49, with a median of 0.52 in 2025.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 133.45% in 2021, then fell by 2.49% in 2025.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Equity Ratio stood at 0.28 in 2021, then skyrocketed by 39.51% to 0.40 in 2022, then surged by 33.88% to 0.53 in 2023, then increased by 7.81% to 0.57 in 2024, then increased by 6.10% to 0.51 in 2025.
  • Its Equity Ratio stands at 0.51 for Q3 2025, versus 0.52 for Q2 2025 and 0.55 for Q1 2025.